Results 31 to 40 of about 701 (178)

Racecadotril

open access: yesReactions Weekly, 2006
europepmc   +3 more sources

Greenness assessment profile of experimentally designed chromatographic method for the simultaneous analysis of ofloxacin and racecadotril in the presence of racecadotril impurities

open access: yesTalanta Open
Experimental design beats the conventional one variable at a time (OVAT) to improve the chromatographic separations with lowest consumption of resources and maximum acceptable results for the separated peaks.
Nada Nabil   +3 more
doaj   +2 more sources

Application of High-Performance Thin-layer Chromatographic Method for Simultaneous Determination of Co-formulated Ofloxacin and Racecadotril in their Oral Dosage Form [PDF]

open access: yesJournal of Advanced Pharmacy Research, 2020
Objectives: This study aimed to develop and validate a simple, rapid, economical, precise and accurate HPTLC method for simultaneous determination of ofloxacin and racecadotril has been developed.
Nasr El-Abasawi   +4 more
doaj   +1 more source

Role of antisecretory drug in treatment of children with acute watery diarrhea: A Randomized Controlled Trial

open access: yesAl-Azhar Assiut Medical Journal, 2022
Background and aim Previous studies have shown that Racecadotril is safer and more effective in treating children with acute diarrhea. This study aimed to evaluate the effect of Racecadotril as a booster to oral rehydration solution in the management of ...
Reham M Sayed   +2 more
doaj   +1 more source

A Scoping Review of Non-Opioid Therapeutics for Opioid Withdrawal: Translational Relevance to Neonatal Opioid Withdrawal Syndrome (NOWS) Research. [PDF]

open access: yesClin Transl Sci
ABSTRACT In the wake of the ongoing opioid epidemic, the incidence of neonatal opioid withdrawal syndrome (NOWS) has surged. While the short‐term effects of NOWS are well‐characterized, long‐term physiological and molecular consequences remain unclear.
Mills-Huffnagle SL   +4 more
europepmc   +2 more sources

APPLICATION OF HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS DETERMINATION OF RACECADOTRIL AND OFLOXACIN IN THEIR PHARMACEUTICAL DOSAGE FORM [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2019
 Racecadotril and ofloxacin are co-formulated for treatment of acute symptomatic diarrhea. In the present work RP-HPLC method was developed for simultaneous determination of racecadotril and ofloxacin in the combined dosage form.
Mohamed Kamel
doaj   +1 more source

Drugs in Focus: The Use of Racecadotril in Paediatric Gastrointestinal Disease [PDF]

open access: yes, 2020
Acute diarrhoea is a leading cause of morbidity and mortality in the paediatric population. Racecadotril is an antisecretory drug recommended as an adjuvant anti-diarrhoeal treatment. In the small bowel, the enzyme neutral endopeptidase (NEP) inhibits
Orel, R   +11 more
core   +2 more sources

Future Prospects of Imatinib in Advanced Pulmonary Hypertension Management. [PDF]

open access: yesIUBMB Life
ABSTRACT Pulmonary arterial hypertension (PAH) is a severe, progressive disease characterized by elevated pulmonary arterial pressure and increased vascular resistance. This hemodynamic strain forces the right ventricle to pump against a high‐pressure system, ultimately leading to right‐sided heart failure and death.
Davì F   +5 more
europepmc   +2 more sources

Ocrelizumab-induced colitis: VigiBase disproportionality analysis, case reports and literature review. [PDF]

open access: yesBr J Clin Pharmacol
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Fresse A   +3 more
europepmc   +2 more sources

Concomitant medication in patients with bradykinin‐mediated angioedema – there's more than ACE inhibitors

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 11, Page 1283-1289, November 2023., 2023
Summary Bradykinin‐mediated angioedema is a rare, non‐allergic, potentially life‐threatening disease. ACE inhibitor‐induced angioedema and hereditary angioedema (HAE) are the two most common presentations. Therapeutic options, pathophysiology and diagnosis continue to be investigated, with considerable progress in HAE over the last few decades. For all
Robin Lochbaum   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy